Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/7/2019
SIETES contiene 92793 citas

 
 
 1 a 13 de 13 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 2018;319:12 de junio. [Ref.ID 102780]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Olfson M, Wall MM, Liu SM, Blanco C. Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry 2018;175:enero. [Ref.ID 102495]
3.Enlace a cita original Cita con resumen
Maust DT, Gerlach LB, Gibson A, Kales HC, Blow FC, Olfson M. Trends in central nervous system – Active polypharmacy among older adults seen in outpatient care in the United States. JAMA Intern Med 2017;177:583-5. [Ref.ID 101408]
4. Cita con resumen
Olfson M, King M, Schoenbaum M. Treatment of young people with antipsychotic medications in the United States. JAMA Psychiatry 2015;72:867-74. [Ref.ID 99254]
5. Cita con resumen
Merikangas KR, He J-P, Rapoport J, Vitiello B, Olfson M. Medication use in US youth with mental disorders. JAMA Pediatrics 2013;167:141-8. [Ref.ID 94613]
6. Cita con resumen
Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito J, Shuster JJ, Olfson M. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ 2012;345:16. [Ref.ID 93565]
7. Cita con resumen
Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito J, Shuster JJ, Olfson M. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ 2012;345:1-12. [Ref.ID 92709]
8.Tiene citas relacionadas Cita con resumen
Huybrechts KF, Gerhard T, Crystal S, Olfson M, Avorn J, Levin R, Lucas JA, Schneeweiss S. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ 2012;344:16. [Ref.ID 92610]
9.Enlace a cita originalTiene citas relacionadas Cita con resumen
Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T. Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009;166:992-1001. [Ref.ID 86051]
10. Cita con resumen
Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE, Wang P, Wells KB, Zaslavsky AM. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005;352:2515-23. [Ref.ID 74078]
11.Tiene citas relacionadas
Olfson M, Marcus S, Druss B, Tanielian T. Changes in the treatment of depression in the United States: 1987-1997. In reply. JAMA 2002;287:1804. [Ref.ID 61474]
12. Cita con resumen
Olfson M, Marcus SC, Druss B, Tanielian T, Pincus H A. National trends in the outpatient treatment of depression. JAMA 2002;287:203-9. [Ref.ID 60643]
13. Cita con resumen
Pincus H A, Tanielian TL, Marcus SC, Olfson M, Zarín DA, Thompson J, Zito JM. Prescribing trends in psychotropic medications. Primary care, psychiatry, and other medical specialties. JAMA 1998;279:526-31. [Ref.ID 37159]
Seleccionar todas
 
 1 a 13 de 13